Russell Investments Group, Ltd. Accelerate Diagnostics, Inc Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$1.01 - $17.0 $137,949 - $2.32 Million	136,584 New	136,584 $207,000
Q1 2022 May 05, 2022	SELL	$1.4 - $5.15 $473,785 - $1.74 Million	-338,418 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$4.27 - $6.97 $1.45 Million - $2.36 Million	338,418 New	338,418 $1.77 Million
Q3 2020 Nov 09, 2020	SELL	$9.98 - $18.04 $215,568 - $389,664	-21,600 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$7.49 - $15.16 $161,784 - $327,456	21,600 New	21,600 $327,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.